To assess Pharmacokinetics, Safety and Tolerability of Ketoconazole with Abt-450/R, Ombitasvir and Dasabuvir in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2016
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ketoconazole
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 12 Mar 2016 Results assessing effect of ketoconazole on paritaprevir pharmacokinetics presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 07 Oct 2015 New trial record